NCT02757820

Brief Summary

The aim of this randomized trial will be to evaluate the clinical performance of the I-gel, air- Q ILA compared with the LMA classic in pediatric patients undergoing peripheral surgery under general anesthesia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Jun 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 28, 2016

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 2, 2016

Completed
1 month until next milestone

Study Start

First participant enrolled

June 14, 2016

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2018

Completed
Last Updated

January 7, 2019

Status Verified

January 1, 2019

Enrollment Period

1.8 years

First QC Date

April 28, 2016

Last Update Submit

January 4, 2019

Conditions

Keywords

anesthesia; airway; laryngeal mask airway; I-gel; Air-Q

Outcome Measures

Primary Outcomes (1)

  • Airway leak pressure

    Airway leak pressure will be determined by closing the adjustable expiratory pressure-limiting (APL) valve and setting the fresh gas flow rate to 3 L/min. The airway pressure at which an audible leak in the mouth is heard is recorded as the "leak pressure". If leak pressure reached 35 cmH2O, the expiratory valve will be opened. After adjusting the APL valve to 35 cmH2O, the maximum tidal volume (TVmax) will be measured by squeezing the balloon of anesthesia circuit until an audible leak occurred. Airway pressures were not allowed to exceed 35 cmH2O.

    intraoperative

Secondary Outcomes (4)

  • Fiberoptic laryngoscopic view

    intraoperative

  • ventilation score

    intraoperative

  • Heart rate

    intraoperative

  • peripheral arterial oxygenation

    intraoperative

Study Arms (3)

LMA classic

ACTIVE COMPARATOR

Patients will be anesthetized using Classic laryngeal mask airway that will be inserted lubricated with partially deflated cuff. After insertion, the cuff will be inflated with the recommended volume of air.

Device: LMA Classic

I-gel

ACTIVE COMPARATOR

Patients will be anesthetized using I-gel LMA with its lubricated cuff inserted along the hard palate until resistance is felt, as recommended by the manufacturer.

Device: i- gel

Air-Q

ACTIVE COMPARATOR

Patients will be anesthetized using Air-Q\_ ILA, with its lubricated cuff inserted along the hard palate until resistance is felt, as recommended by the manufacturer.

Device: Air-Q

Interventions

Patients will be anesthetized using Classic laryngeal mask airway that will be inserted lubricated with partially deflated cuff. After insertion, the cuff will be inflated with the recommended volume of air.

LMA classic
i- gelDEVICE

Patients will be anesthetized using I-gel LMA with its lubricated cuff inserted along the hard palate until resistance is felt, as recommended by the manufacturer.

I-gel
Air-QDEVICE

Patients will be anesthetized using Air-Q\_ ILA, with its lubricated cuff inserted along the hard palate until resistance is felt, as recommended by the manufacturer.

Air-Q

Eligibility Criteria

Age2 Years - 9 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Weight: 15-30 kg. Age: 2-9 years. Sex: both males and females. ASA physical status: 1-3. Operation: elective outpatient surgery in which airway management with a LMA would be appropriate.

You may not qualify if:

  • Active respiratory illness (cough, fever, rhinorrhea) on the day of anesthesia, Potentially difficult airway. Patients with history of neck, respiratory, or digestive tract pathology. Patients with gastroesophageal reflux, gastrointestinal stenosis or stricture

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assiut university Pediatric hospital

Asyut, Assiut Governorate, 715715, Egypt

Location

Study Officials

  • Hala S Abdel-Ghaffar, MD

    Assistant professor, anesthesia department, faculty of medicine, Assiut university

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant professor

Study Record Dates

First Submitted

April 28, 2016

First Posted

May 2, 2016

Study Start

June 14, 2016

Primary Completion

April 1, 2018

Study Completion

April 1, 2018

Last Updated

January 7, 2019

Record last verified: 2019-01

Locations